ZHONGSHENGYAOYE(SZ:002317) Xin Lang Cai Jing·2025-10-22 03:51Core Insights - Zhongsheng Pharmaceutical's stock price increased by 5.71% on October 22, reaching 19.44 CNY per share, with a trading volume of 938 million CNY and a turnover rate of 6.51%, resulting in a total market capitalization of 16.523 billion CNY. The stock has risen for three consecutive days, with a cumulative increase of 7.61% during this period [1] Company Overview - Guangdong Zhongsheng Pharmaceutical Co., Ltd. is located in Dongguan City, Guangdong Province, and was established on December 31, 2001. The company was listed on December 11, 2009. Its main business involves the research, production, and sales of pharmaceuticals [1] - The revenue composition of Zhongsheng Pharmaceutical includes: Traditional Chinese Medicine sales at 53.03%, chemical drug sales at 38.12%, Chinese medicinal materials and decoction pieces sales at 6.13%, raw materials and intermediates sales at 2.14%, and other sales at 0.58% [1] Fund Holdings - According to data from the top ten holdings of funds, one fund under Debon Fund has a significant position in Zhongsheng Pharmaceutical. The Debon Technology Innovation One-Year Open Mixed A Fund (009432) held 218,900 shares in the second quarter, accounting for 4.78% of the fund's net value, making it the fourth-largest holding. The estimated floating profit today is approximately 229,800 CNY, with a floating profit of 284,600 CNY during the three-day increase [2] - The Debon Technology Innovation One-Year Open Mixed A Fund (009432) was established on November 24, 2020, with a current scale of 59.358 million CNY. Year-to-date returns are 50.53%, ranking 829 out of 8160 in its category; the one-year return is 50.93%, ranking 738 out of 8026; and since inception, the return is 14.51% [2]